Literature DB >> 15717119

Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain.

C C Carter1, V Y Gorbacheva, D J Vestal.   

Abstract

Interferons (IFNs) exert their anti-viral activities through the induction of anti-viral proteins. One member of the guanylate binding protein (GBP) family of IFN-induced GTPases, hGBP-1, has previously been shown to contribute to the antiviral activities of IFNs. Murine GBP-2 inhibited the replication of both vesicular stomatitis virus (VSV) and encephalomyocarditis virus (EMCV). A wild type GTP binding motif was not required for VSV inhibition but was required for inhibition of EMCV. This is the first demonstration of the role of enzymatic activity in the antiviral activities of GBPs and these findings suggest different mechanisms of inhibition for the two viruses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717119     DOI: 10.1007/s00705-004-0489-2

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  40 in total

1.  Dimerization and its role in GMP formation by human guanylate binding proteins.

Authors:  Nazish Abdullah; Meena Balakumari; Apurba Kumar Sau
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

2.  The GTPase activity of murine guanylate-binding protein 2 (mGBP2) controls the intracellular localization and recruitment to the parasitophorous vacuole of Toxoplasma gondii.

Authors:  Elisabeth Kravets; Daniel Degrandi; Stefanie Weidtkamp-Peters; Britta Ries; Carolin Konermann; Suren Felekyan; Julia M Dargazanli; Gerrit J K Praefcke; Claus A M Seidel; Lutz Schmitt; Sander H J Smits; Klaus Pfeffer
Journal:  J Biol Chem       Date:  2012-06-22       Impact factor: 5.157

3.  Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts.

Authors:  Tao Peng; Jia Zhu; Yon Hwangbo; Lawrence Corey; Roger E Bumgarner
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

4.  Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B.

Authors:  Simon P Fletcher; Daniel J Chin; Donavan T Cheng; Palanikumar Ravindran; Hans Bitter; Lore Gruenbaum; Paul J Cote; Han Ma; Klaus Klumpp; Stephan Menne
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

Review 5.  New developments in the induction and antiviral effectors of type I interferon.

Authors:  Su-Yang Liu; David Jesse Sanchez; Genhong Cheng
Journal:  Curr Opin Immunol       Date:  2010-11-29       Impact factor: 7.486

6.  Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication.

Authors:  Daniel Degrandi; Elisabeth Kravets; Carolin Konermann; Cornelia Beuter-Gunia; Verena Klümpers; Sarah Lahme; Eva Rasch; Anne K Mausberg; Sandra Beer-Hammer; Klaus Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

7.  Allergen challenge induces Ifng dependent GTPases in the lungs as part of a Th1 transcriptome response in a murine model of allergic asthma.

Authors:  Nilesh Dharajiya; Swapnil Vaidya; Mala Sinha; Bruce Luxon; Istvan Boldogh; Sanjiv Sur
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

8.  The interferon-gamma-induced murine guanylate-binding protein-2 inhibits rac activation during cell spreading on fibronectin and after platelet-derived growth factor treatment: role for phosphatidylinositol 3-kinase.

Authors:  Angela F Messmer-Blust; Sujata Balasubramanian; Victoria Y Gorbacheva; Jonathan A Jeyaratnam; Deborah J Vestal
Journal:  Mol Biol Cell       Date:  2010-05-26       Impact factor: 4.138

9.  Alpha/beta interferon inhibits cap-dependent translation of viral but not cellular mRNA by a PKR-independent mechanism.

Authors:  Mulu Z Tesfay; Jun Yin; Christina L Gardner; Mikhail V Khoretonenko; Nadejda L Korneeva; Robert E Rhoads; Kate D Ryman; William B Klimstra
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

10.  Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma.

Authors:  Illya Tietzel; Christelle El-Haibi; Rey A Carabeo
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.